Alteration of Enzyme Expressions in Mevalonate Pathway

DOI Web Site 被引用文献4件 参考文献90件
  • Han Jie
    Institute of Cardiology, The First Affiliated Hospital, College of Medicine, Zhejiang University
  • Jiang Dong-Mei
    Institute of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
  • Du Chang-Qing
    Institute of Cardiology, The First Affiliated Hospital, College of Medicine, Zhejiang University
  • Hu Shen-Jiang
    Institute of Cardiology, The First Affiliated Hospital, College of Medicine, Zhejiang University

書誌事項

タイトル別名
  • – Possible Role for Cardiovascular Remodeling in Spontaneously Hypertensive Rats –

この論文をさがす

説明

Background: The mevalonate pathway is an important metabolic pathway that plays a key role in multiple cellular processes. The aim of this study was to define whether the enzyme expression in mevalonate pathway changes during cardiovascular remodelling in spontaneously hypertensive rats (SHR). Methods and Results: Hearts and thoracic aortas were removed for the study of cardiovascular remodeling in SHR and Wistar-Kyoto rats (WKY). The protein expression of the enzymes in hearts, aortas and livers was analyzed by western blot. The histological measurements showed that the mass and the size of cardiomyocytes, the media thickness and the media cross-sectional area (MCSA) of the thoracic aorta were all increased in SHR since 3 weeks of age. In the heart, there was overexpression of some enzymes, including 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR), farnesyl diphosphate synthase (FDPS), and geranylgeranyltransferase type I (GGTase-I), and downregulation of squalene synthetase (SQS) in SHR since 3 weeks of age. In the aorta, besides similar expressions of HMGR, SQS, FDPS and GGTase-I as in the heart, there was upregulation of farnesyltransferase α at 16 and 25 weeks of age and of farnesyltransferase β in 25-weeks-old SHR. Western blot demonstrated overexpression of HMGR and downregulation of SQS in SHR livers at all ages tested. Conclusions: The cardiovascular remodeling of SHR preceded the development of hypertension, and altered expression of several key enzymes in the mevalonate pathway may play a potential pathophysiological role in cardiovascular remodeling. (Circ J 2011; 75: 1409-1417)<br>

収録刊行物

  • Circulation Journal

    Circulation Journal 75 (6), 1409-1417, 2011

    一般社団法人 日本循環器学会

被引用文献 (4)*注記

もっと見る

参考文献 (90)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ